- Home
- Services
- usa california
- drug discovery assay onboarding and development
Show results for
Refine by
Drug Discovery Assay Onboarding And Development Services In Usa California
10 services found
by:Strateos Inc. based inMenlo Park, CALIFORNIA (USA)
Strateos offers a wide range of off the shelf drug discovery assays and supports custom development of biochemical, biophysical and cell based assays in drug discovery, using both industry-standard and innovative technologies to support drug screening projects from hit identification to lead ...
by:Sutro Biopharma Inc. based inSouth San Francisco, CALIFORNIA (USA)
Sutro’s Research and Development Collaborations allow our partners to leverage our drug discovery and development capabilities and our proprietary XpressCF® cell-free protein synthesis and XpressCF+® site-specific conjugation platforms. Our proprietary technologies enable precision design and rapid empirical optimization of protein therapeutics and protein conjugates; and our cGMP ...
Manufactured by:Charles River based inHollister, CALIFORNIA (USA)
With Charles River's Insourcing Solutions, we provide customized workplace solutions that seamlessly integrate into your research program, becoming an extension of your own facility. Offering staffing, training, consulting and other animal facility support services - we help clients streamline their drug discovery and development programs to make best use of their resources and achieve optimum ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Invicro has a vast range of tools that help accelerate your drug discovery and development process. Our technology platforms support key decision-making in: Early discovery and screening. Candidate selection. First-in-human translation and early development. Late stage, multi-center determination of ...
Manufactured by:Charles River based inHollister, CALIFORNIA (USA)
Market pressures continue to change the focus and structure of the drug development industry with a heavy emphasis on accelerating preclinical development to move the most efficacious therapies into the clinic. The preclinical drug development journey is rarely straight and often requires course corrections and pivots. ...
by:Strateos Inc. based inMenlo Park, CALIFORNIA (USA)
One of the challenges in drug discovery and development is miniaturization. Miniaturization is key to automating small molecule discovery, facilitating higher throughput, increasing reliability and accuracy and reducing costs for screening large compound libraries. We have a solid track record in miniaturizing challenging assays to 384- and 1536-well formats for medium to Ultra-High-Throughput ...
Manufactured by:Novartis International AG based inBasel, SWITZERLAND
We are an innovative medicines company with research and development at our core. Our R&D engine powers an industry-leading pipeline focused on delivering transformative medicines to fight disease, restore possibility and help people live life on their own terms. Researchers in Biomedical Research work across several diseases areas to uncover insights into the origins and pathogenesis of ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Invicro’s Advanced Pathology Services (APS) team provides end-to-end solutions to support translational and clinical research by providing a combination of routine and unique tissue testing services. As part of the REALM IDx, Inc. group, our pathology service laboratories support projects spanning preclinical biomarker discovery research to clinical trials and development of companion ...
Manufactured by:Charles River based inHollister, CALIFORNIA (USA)
Discovering and characterizing novel drug candidates for preclinical development depends on innovative and reliable science. Our unique combination of integrated, multidisciplinary drug discovery expertise and unparalleled scope of capabilities in targets, platforms, and therapeutic areas allow us to deliver depth and breadth in science with data and insight you can trust to progress your drug ...
Manufactured by:XILIS, Inc. based inDurham, NORTH CAROLINA (USA)
Xilis’ rapid and scalable patient-derived MicroOrganoSphere (MOS) technology platform enhances precision medicine and pharmaceutical drug discovery and development. Compared to conventional patient-derived models, MOS provides faster, higher-throughput, and greater cost savings, as well as more predictive and accurate results. MOS can be used in large-scale pharmacogenomic studies that are ...